Weekly high-dose 5-fluorouracil as 24-hour infusion combined with sodium folinic acid (AIO regimen) plus irinotecan in second-line and sequential therapy of metastatic colorectal cancer (CRC)
Background/Aim: The aim of this work was to evaluate the efficacy and safety of second-line treatment with weekly high-dose 5-fluorouracil (5-FU) as a 24-hour infusion (24-h inf.) combined with sodium folinic acid (FA) (AIO-regimen) plus irinotecan (Iri.) after pretreatment with AIO-regimen plus oxa...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
July 2017
|
| In: |
Anticancer research
Year: 2017, Jahrgang: 37, Heft: 7, Pages: 3771-3779 |
| ISSN: | 1791-7530 |
| DOI: | 10.21873/anticanres.11752 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.21873/anticanres.11752 Verlag, Volltext: http://ar.iiarjournals.org/content/37/7/3771 
|
| Verfasserangaben: | Axel Wein, Juergen Siebler, Kerstin Wolff, Nicola Ostermeier, Dagmar Busse, Alexander Hagel, Franz Koch, Kirsten Merx, Markus Friedrich Neurath and Ralf-Dieter Hofheinz |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1582434417 | ||
| 003 | DE-627 | ||
| 005 | 20230427193220.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181030s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21873/anticanres.11752 |2 doi | |
| 035 | |a (DE-627)1582434417 | ||
| 035 | |a (DE-576)512434417 | ||
| 035 | |a (DE-599)BSZ512434417 | ||
| 035 | |a (OCoLC)1341021838 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wein, Axel |e VerfasserIn |0 (DE-588)1170200168 |0 (DE-627)1037636430 |0 (DE-576)512434190 |4 aut | |
| 245 | 1 | 0 | |a Weekly high-dose 5-fluorouracil as 24-hour infusion combined with sodium folinic acid (AIO regimen) plus irinotecan in second-line and sequential therapy of metastatic colorectal cancer (CRC) |c Axel Wein, Juergen Siebler, Kerstin Wolff, Nicola Ostermeier, Dagmar Busse, Alexander Hagel, Franz Koch, Kirsten Merx, Markus Friedrich Neurath and Ralf-Dieter Hofheinz |
| 264 | 1 | |c July 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.10.2018 | ||
| 520 | |a Background/Aim: The aim of this work was to evaluate the efficacy and safety of second-line treatment with weekly high-dose 5-fluorouracil (5-FU) as a 24-hour infusion (24-h inf.) combined with sodium folinic acid (FA) (AIO-regimen) plus irinotecan (Iri.) after pretreatment with AIO-regimen plus oxaliplatin (L-OHP). Patients and Methods: Patients with non-resectable distant CRC metastases were enrolled in a prospective phase II study for palliative second-line treatment after previous progression of first-line treatment in accordance with the AIO-regimen plus oxaliplatin. On an outpatient basis, the patients received a treatment regimen comprising of weekly 80 mg/m2 irinotecan in the form of a 1-hour i.v. infusion and 2,000 mg/m2 5-FU combined with 500 mg/m2 sodium folinic acid administered as a 24-h infusion i.v. once weekly. Results: During second-line treatment, a total of 59 patients received 520 chemotherapy applications. As the main higher-grade symptom of toxicity, diarrhea (NCI-CTC-toxicity grade 3) presented in 8 patients (13.6%, 95%CI=5.1-23.7), followed by leukocytopenia (CTC grade 3) in 3 patients (5.1%, 95%CI=0-11.9), followed by thrombocytopenia (CTC grade 3) in 1 patient (1.7%, 95%CI=0-5.1). Fifty-nine patients were evaluable for treatment response. The remission data can be summarized as follows: complete remission (CR); n=0; partial remission (PR); n=6 (10%; 95%CI=3.4-18.6); stable disease (SD); n=31 (53%; 95%CI=39.0-64.4); progressive disease (PD); n=19 (33%; 95%CI=20.3-44.1). The median progression-free survival (PFS) rate (n=59) was 4.2 months (range=3.8-5.8 months). The median survival time counted from the start of second-line treatment (n=59) 14.2 months (range 8.2-17.3 months) and the median survival time counted from the start of first-line therapy (n=59) 25 months (range 19-27 months). Conclusion: Palliative second-line treatment according to the AIO regimen plus irinotecan offers both a favourable toxicity profile and promising efficacy in second-line and palliative sequential therapy. | ||
| 650 | 4 | |a Colorectal cancer | |
| 650 | 4 | |a palliative sequential therapy | |
| 650 | 4 | |a second-line AIO plus irinotecan | |
| 700 | 1 | |a Merx, Kirsten |d 1970- |e VerfasserIn |0 (DE-588)122413091 |0 (DE-627)70589892X |0 (DE-576)293258910 |4 aut | |
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anticancer research |d Kapandriti, Attiki, Greece : International Institute of Anticancer Research, 2004 |g 37(2017), 7, Seite 3771-3779 |h Online-Ressource |w (DE-627)387478493 |w (DE-600)2145376-7 |w (DE-576)358408717 |x 1791-7530 |7 nnas |a Weekly high-dose 5-fluorouracil as 24-hour infusion combined with sodium folinic acid (AIO regimen) plus irinotecan in second-line and sequential therapy of metastatic colorectal cancer (CRC) |
| 773 | 1 | 8 | |g volume:37 |g year:2017 |g number:7 |g pages:3771-3779 |g extent:9 |a Weekly high-dose 5-fluorouracil as 24-hour infusion combined with sodium folinic acid (AIO regimen) plus irinotecan in second-line and sequential therapy of metastatic colorectal cancer (CRC) |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21873/anticanres.11752 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://ar.iiarjournals.org/content/37/7/3771 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181030 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 10 |y j | ||
| 998 | |g 122413091 |a Merx, Kirsten |m 122413091:Merx, Kirsten |d 60000 |d 61200 |e 60000PM122413091 |e 61200PM122413091 |k 0/60000/ |k 1/60000/61200/ |p 8 | ||
| 999 | |a KXP-PPN1582434417 |e 3030098362 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"Weekly high-dose 5-fluorouracil as 24-hour infusion combined with sodium folinic acid (AIO regimen) plus irinotecan in second-line and sequential therapy of metastatic colorectal cancer (CRC)","title_sort":"Weekly high-dose 5-fluorouracil as 24-hour infusion combined with sodium folinic acid (AIO regimen) plus irinotecan in second-line and sequential therapy of metastatic colorectal cancer (CRC)"}],"relHost":[{"title":[{"title":"Anticancer research","subtitle":"international journal of cancer research and treatment","title_sort":"Anticancer research"}],"language":["eng"],"part":{"issue":"7","extent":"9","pages":"3771-3779","volume":"37","year":"2017","text":"37(2017), 7, Seite 3771-3779"},"pubHistory":["Nachgewiesen 24.2004 -"],"name":{"displayForm":["International Institute of Anticancer Research"]},"id":{"eki":["387478493"],"zdb":["2145376-7"],"issn":["1791-7530"]},"disp":"Weekly high-dose 5-fluorouracil as 24-hour infusion combined with sodium folinic acid (AIO regimen) plus irinotecan in second-line and sequential therapy of metastatic colorectal cancer (CRC)Anticancer research","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 26.02.13"],"recId":"387478493","origin":[{"dateIssuedDisp":"2004-","publisher":"International Institute of Anticancer Research","dateIssuedKey":"2004","publisherPlace":"Kapandriti, Attiki, Greece"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"note":["Gesehen am 30.10.2018"],"physDesc":[{"extent":"9 S."}],"id":{"doi":["10.21873/anticanres.11752"],"eki":["1582434417"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"July 2017"}],"recId":"1582434417","person":[{"display":"Wein, Axel","role":"aut","given":"Axel","family":"Wein"},{"given":"Kirsten","role":"aut","display":"Merx, Kirsten","family":"Merx"},{"display":"Hofheinz, Ralf-Dieter","given":"Ralf-Dieter","role":"aut","family":"Hofheinz"}],"name":{"displayForm":["Axel Wein, Juergen Siebler, Kerstin Wolff, Nicola Ostermeier, Dagmar Busse, Alexander Hagel, Franz Koch, Kirsten Merx, Markus Friedrich Neurath and Ralf-Dieter Hofheinz"]}} | ||
| SRT | |a WEINAXELMEWEEKLYHIGH2017 | ||